Depression and Anxiety Trial, Recruiting NCT06778096 Sponsor: Université de Sherbrooke Condition: Depression and Anxiety
Back to Depression And Anxiety

Depression and Anxiety Trial, Recruiting

NCT06778096
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 18 years of age or older
  • People who are within 12 months of giving birth
  • People who are fluent in spoken and written French
  • People who score 10 or higher on standardised questionnaires measuring anxiety (GAD-7) and/or postnatal depression (EPDS), based on self-reported answers
  • People who have access to a computer or tablet with an internet connection
  • People who are willing to share their primary healthcare provider's contact information with the trial team

Who may not be able to join:

  • People who have been diagnosed with schizophrenia or bipolar disorder
  • People who are currently struggling with substance abuse or dependence
  • People who are currently taking benzodiazepines (a type of medication often used for anxiety or sleep)
  • People who started psychological therapy less than 4 weeks ago, or started medication for depression or anxiety less than 8 weeks ago
  • People whose depression questionnaire score is very high (EPDS score of 23 or above), or who are experiencing active thoughts of suicide (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 7 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Pasquale Roberge, PhD, Université de Sherbrooke

Phone: 819 821-8000

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Université de Sherbrooke
Registry
ClinicalTrials.gov
Start date
1 May 2025
Est. completion
1 July 2026

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Edinburgh Postnatal Depression Scale (French); Generalised Anxiety Disorder-7 (French)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov